About Us>Medical Advisory Board > Pallav K. Mehta, MD

Pallav K. Mehta, MD

Chief Medical Officer, Main Street Health; Medical Director, Reimagine Care; Assistant Professor of Medicine, MD Anderson Cancer Center at Cooper

Pallav Mehta

Highlights

Connect

Cooper Health
featured_paragraph

Pallav Mehta, MD, is a medical oncologist/hematologist with expertise and interest in breast cancer and integrative oncology. He is board certified in medical oncology, hematology, and integrative medicine with previous board certification in internal medicine.

general_content

Dr. Mehta serves as chief medical officer of oncology at Main Street Health, where he focuses on improving cancer care for people living in rural communities. He is also medical director of Reimagine Care, a tech-enabled, human-led startup company working to transform the cancer care experience for patients and care teams. In addition, Dr. Mehta is assistant professor of medicine at Cooper Medical School, Rowan University, and director of integrative oncology and practice development at MD Anderson Cancer Center at Cooper in Camden, New Jersey, where he specializes in breast cancer and integrative oncology.

While being published in the medical literature and serving as principal investigator on several active clinical trials, Dr. Mehta also co-authored After Cancer Care: The Definitive Self-Care Guide to Getting and Staying Well for Patients after Cancer, which provides evidence-based information to patients regarding lifestyle intervention after cancer treatment. The book is an international bestseller and has been translated into three languages.

Dr. Mehta has received over 30 Castle Connolly “Top Doc” distinctions regionally and nationally in cancer care, women’s health, breast cancer and integrative oncology.

quote_style_1

The relationship that is developed between a patient and their oncologist is one that is unique in all of medicine. I truly appreciate and enjoy the opportunity to guide my patients through what is often a frightening and life-changing experience. I firmly believe in utilizing standard of care and cutting-edge cancer therapies, while also understanding the importance of the patient as a human being, incorporating topics such as optimizing nutrition or exercise with every patient I meet. I am always grateful that this wonderful profession provides me with personal and professional fulfillment at every level.

Dr. Pallav Mehta

video
3_column_content

Experience & accolades

Expertise

  • Medical oncology
  • Hematology

Education

Experience

Awards & distinctions

Professional memberships & board positions

Publications

contributions_carousel

Contributions

Biomarker testing

06/26/26 | BY: Pallav K. Mehta, Adam Brufsky

A biomarker is a protein, gene mutation, or other substance that can be tested using a sample of cancer tissue or blood. Biomarker test results can help you and your doctor better understand your cancer and treatment options.

Read More
 | 22 Min. Read

HER2-positive or HER2-low

05/18/26 | BY: Pallav K. Mehta

HER2-positive or HER2-low breast cancer is caused by a genetic mutation in the HER2 gene. Learn more about the causes and treatment options for this type of breast cancer.

Read More
 | 14 Min. Read

Metastatic breast cancer symptoms

03/22/26 | BY: Pallav K. Mehta

Metastatic breast cancer can cause a range of symptoms. Learn how to recognize potential symptoms and when to see your doctor.

Read More
 | 10 Min. Read

Living with Metastatic Breast Cancer

02/24/26 | BY: Pallav K. Mehta

Living with a metastatic breast cancer diagnosis can be overwhelming, but there are many ways to adapt to your situation and find the support you need.

Read More
 | 11 Min. Read

FDA approval programs

12/08/25 | BY: Lisa Carey, Pallav K. Mehta

It takes years for researchers to study a medicine’s safety and effectiveness, but the FDA has programs to make medicines available sooner for those in need.

Read More
 | 8 Min. Read

Circulating tumor DNA (ctDNA) tests

11/26/25 | BY: Pallav K. Mehta

A ctDNA test, or liquid biopsy, looks for cancer cell DNA in the blood. ctDNA tests can help match a cancer to a treatment or find minimal residual disease (MRD)—areas of cancer too small to show up on a scan.

Read More
 | 25 Min. Read

Living well with metastatic breast cancer

07/07/25 | BY: Pallav K. Mehta

A metastatic breast cancer diagnosis can be one of the biggest challenges of your life, but there are many ways to continue living well emotionally and physically.

Read More
 | 6 Min. Read

Living with and treating bone metastasis

03/08/25 | BY: Pallav K. Mehta

From our 2025 Conference on Metastatic Breast Cancer, Pallav Mehta, MD, shares information about bone metastases, including screening tests, treatment options, strategies to limit side effects, managing bone pain, and maintaining bone strength.

Read More
 | 59 Min. Read

Next-generation sequencing (NGS) tests

11/18/24 | BY: Pallav K. Mehta

Next-generation sequencing (NGS) is a testing technology that uses computers to look at hundreds of genes in cancer cells. The results can help guide treatment decisions.

Read More
 | 7 Min. Read

How breast cancer is staged

04/19/23 | BY: Pallav K. Mehta

Breast cancer staging (0-5) describes the extent of the cancer in the breast and body. Learn more about what your staging diagnosis may mean for you.

Read More
 | 21 Min. Read

Inflammatory

08/20/19 | BY: Pallav K. Mehta

Inflammatory breast cancer, or IBC, is an aggressive type of invasive breast cancer that usually doesn’t form a lump.

Read More
 | 8 Min. Read

DCIS

08/31/15 | BY: Pallav K. Mehta

In ductal carcinoma in situ, also called DCIS, abnormal cells are found in the lining of the milk ducts, the tubes that carry milk to the nipple. It is also called intraductal carcinoma.

Read More
 | 6 Min. Read